Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes treatment and weight management research. Our pharmaceutical grade tirzepatide for sale meets the highest purity standards at 99% concentration.
This innovative peptide demonstrates superior efficacy in glucose control and weight reduction compared to selective GLP-1 receptor agonists. The molecular structure features PEG modification on the lys side chain, enhancing water solubility while maintaining biological activity.
Clinical studies indicate significant weight loss potential, with SURMOUNT-1 trial results showing 15-20.9% average weight reduction after 72 weeks across different dosage levels (5mg, 10mg, 15mg). The FDA has granted Fast Track designation for obesity treatment applications.
Our tirzepatide for sale is supplied in sterile vials (10mg/vial, 10vials/box) with secure pharmaceutical packaging. The white powder form ensures stability and easy reconstitution for research purposes.
As a dual agonist, tirzepatide combines the metabolic benefits of both GIP and GLP-1 pathways, representing a novel approach in diabetes and obesity research. The compound mimics natural GIP action while delivering enhanced GLP-1 receptor activity.
Proper storage is essential for maintaining peptide integrity. We recommend storing tirzepatide in a cool, dry, dark environment, avoiding repeated freeze-thaw cycles and prolonged exposure to air or light.
This product is intended for research use only. Not for human consumption. Researchers should follow all applicable safety protocols when handling this compound.
